Search Results
Oct 28, 2025, 08:00 ET Cognex Introduces the Solutions Experience (SLX) Logistics Portfolio
(NASDAQ: CGNX), the global technology leader in industrial machine vision, today announced the launch of its first line of Solutions Experience (SLX ™) devices, application-specific solutions designed to easily solve the most critical applications in key industrial verticals.
More news about: Cognex Corporation
Oct 28, 2025, 08:00 ET A Cognex apresenta o portfólio Solutions Experience (SLX) para logística
líder global em tecnologia de visão industrial para máquinas, anunciou hoje o lançamento de sua primeira linha de produtos Solutions Experience (SLX ™), soluções específicas para aplicações, projetadas para resolver facilmente as aplicações mais críticas em setores industriais importantes.
More news about: Cognex Corporation
Oct 28, 2025, 08:00 ET Cognex presenta la cartera de soluciones logísticas Solutions Experience (SLX)
CGNX), líder tecnológico mundial en visión artificial industrial, anunció el lanzamiento de su primera línea de productos Solutions Experience (SLX ™), soluciones específicas para cada aplicación, diseñadas para resolver con facilidad las aplicaciones más importantes en sectores industriales clave.
More news about: Cognex Corporation
Oct 28, 2025, 07:30 ET Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System
Iodine technology integrates a controlled-release iodine surface treatment into the iTaperloc® Complete and iG7™ Hip System to help address challenges associated with joint replacement procedures for patients at higher risk of infection. This system recently
More news about: Zimmer Biomet Holdings, Inc.
Oct 28, 2025, 07:15 ET CSL wurde von der International Society for Pharmaceutical Engineering (ISPE) als Gesamtsieger der „2025 Facility of the Year Awards" ausgezeichnet
Das Werk von CSL in Broadmeadows setzt neue Maßstäbe für verantwortungsbewusste Innovation und verbindet die Prinzipien von Pharma 4.0™ mit nachhaltigem Design, um die Plasma-Herstellung zu transformieren BROADMEADOWS,
More news about: CSL
Oct 28, 2025, 06:59 ET Garmin expands flagship chartplotter lineup with premium GPSMAP 9000xsv for the ultimate experience at the helm
Navigate with preloaded Garmin Navionics+™charts with Auto Guidance+ technology2, or update to Garmin Navionics Vision+™ charts for premium features such as high-resolution relief shading, satellite imagery and more. Build extensive
More news about: Garmin International, Inc.
Oct 28, 2025, 02:00 ET Meiyume na targach Cosmopack Asia 2025: SEEDED - zakorzenione w inteligencji, połączone wiązkami przewodzącymi piękno
https://mma.prnewswire.com/media/2802799/without_tm_meiyume_logo_Logo.jpg
More news about: Meiyume
Oct 28, 2025, 02:00 ET Meiyume at Cosmopack Asia 2025: SEEDED -- Rooted in Intelligence, Connected Through the Beauty Vein
https://mma.prnewswire.com/media/2802799/without_tm_meiyume_logo_Logo.jpg
More news about: Meiyume
Oct 28, 2025, 02:00 ET Meiyume auf der Cosmopack Asia 2025: SEEDED - Verwurzelt in der Intelligenz, verbunden durch die Schönheitsvene
https://mma.prnewswire.com/media/2802799/without_tm_meiyume_logo_Logo.jpg
More news about: Meiyume
Oct 28, 2025, 02:00 ET Meiyume na veletrhu Cosmopack Asia 2025: ZASETO - zakořeněno v inteligenci, propojeno duchem krásy
https://mma.prnewswire.com/media/2802799/without_tm_meiyume_logo_Logo.jpg
More news about: Meiyume
Oct 28, 2025, 02:00 ET Meiyume na Cosmopack Asia 2025: SEEDED -- Enraizada na Inteligência, Conectada Através da Veia da Beleza
https://mma.prnewswire.com/media/2805763/without_tm_meiyume_logo_Logo.jpg
More news about: Meiyume
Oct 27, 2025, 16:05 ET Lilly's Omvoh (mirikizumab-mrkz) approved by U.S. FDA as a single-injection maintenance regimen in adults with ulcerative colitis
the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not
More news about: Eli Lilly and Company
Oct 27, 2025, 14:00 ET ISPE Names CSL Behring the 2025 ISPE Facility of the Year Awards (FOYA) Overall Winner for its Project Aurora Plasma Base Fractionation Facility (Facility F)
to life. From advanced automation and robotics to sustainable design and end-to-end scalability, this facility sets a new benchmark for what Pharma 4.0™ integration can achieve. It's a blueprint for the future of biomanufacturing," said Mike Martin, President and CEO of ISPE. CSL
More news about: ISPE
Oct 27, 2025, 12:41 ET Opus IVS™ Expands Innovation Leadership with 8 New Patents and 3 Additional Approvals
Experience the difference at SEMA in Las Vegas Opus IVS will showcase DrivePro2™ and DriveSafe2™, along with many other new product offerings at this year's Specialty Equipment Market Association (SEMA) Show to run November 4 - 7 in Las
More news about: Opus IVS
Oct 27, 2025, 10:44 ET CSL reconnu par l'International Society for Pharmaceutical Engineering (ISPE) en tant que lauréat du prix de l'installation de l'année 2025
Établissant de nouvelles normes en matière d'innovation responsable, l'installation de CSL à Broadmeadows mélange les principes de Pharma 4.0™ avec une conception durable pour transformer la fabrication du plasma. BROADMEADOWS,
More news about: CSL
Oct 27, 2025, 10:20 ET Chromatin Bioscience Announces Collaboration with Purespring Therapeutics
help unlock the full therapeutic potential of next-generation gene therapies." Chromatin Bioscience's chromatinLENS TM platform identifies highly specific gene regulatory elements from the dark genome and integrates them into synthetic promoters optimised for target
More news about: CHROMATIN BIOSCIENCE LTD
Oct 27, 2025, 10:15 ET Chromatin Bioscience Announces Collaboration with Purespring Therapeutics
help unlock the full therapeutic potential of next-generation gene therapies." Chromatin Bioscience's chromatinLENS TM platform identifies highly specific gene regulatory elements from the dark genome and integrates them into synthetic promoters optimised for target
More news about: CHROMATIN BIOSCIENCE LTD
Oct 27, 2025, 09:01 ET Candy Crush Solitaire™ Deals in Love: The Care Bears™ Join the Game for a Season of Sweet Kindness
www.candycrushsolitaire.com. © /TM / ® 2025
More news about: Candy Crush Saga
Oct 27, 2025, 08:44 ET First Citizens Bank Announces Boston Market Expansion, Real Estate Purchase
Citizens BancShares, Inc. (NASDAQ: FCNCA) is a top 20 U.S. financial institution with more than $200 billion in assets and a member of the Fortune 500™. Discover more at firstcitizens.com. About First Citizens Wealth
More news about: First Citizens Bank
Oct 27, 2025, 07:00 ET Mphasis Launches NeoIP™, a unified AI Platform for continuous Enterprise Transformation
Front2Back™ transformation framework, which uses the exponential power of cloud and cognitive to deliver hyper-personalized digital experiences (C=X2C2™ = 1) and build strong relationships with marquee clients. Our Service Transformation solutions enable enterprises pivot from legacy systems and operations
More news about: Mphasis
Oct 27, 2025, 06:45 ET Lilly's Omvoh (mirikizumab-mrkz) demonstrated early and sustained improvement in bowel urgency outcomes for patients with ulcerative colitis
the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not
More news about: Eli Lilly and Company
Oct 27, 2025, 06:00 ET Hemab Therapeutics Announces $157 Million Series C Financing to Advance Next-Generation Treatments for Underserved Bleeding Disorders
cutting-edge technologies and approaches to transform the treatment paradigm for patients with high unmet need. The company's strategic guidance, Hemab 1-2-5TM, targets building a pipeline of development programs to deliver long-awaited innovation for people with high unmet need diseases like Glanzmann
More news about: Hemab Therapeutics
Oct 26, 2025, 23:20 ET CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards by the International Society for Pharmaceutical Engineering (ISPE)
Setting new standards in responsible innovation, CSL's Broadmeadows facility blends Pharma 4.0™ principles with sustainable design to transform plasma manufacturing BROADMEADOWS, AUSTRALIA,
More news about: CSL
Oct 26, 2025, 22:30 ET CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards by the International Society for Pharmaceutical Engineering (ISPE)
Setting new standards in responsible innovation, CSL's Broadmeadows facility blends Pharma 4.0™ principles with sustainable design to transform plasma manufacturing BROADMEADOWS, AUSTRALIA,
More news about: CSL